Cancer immunotherapy (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cancer immunotherapy (unspecified), covering 2024-06-14 to 2024-06-14. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site [Phase 2]